Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Macrogenics (MGNX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Macrogenics (MGNX) over the last 13 years, with Q3 2025 value amounting to 0.53%.

  • Macrogenics' Return on Capital Employed rose 900.0% to 0.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.53%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 0.49% for FY2024, which is 2300.0% up from last year.
  • Per Macrogenics' latest filing, its Return on Capital Employed stood at 0.53% for Q3 2025, which was up 900.0% from 0.4% recorded in Q2 2025.
  • In the past 5 years, Macrogenics' Return on Capital Employed ranged from a high of 0.34% in Q2 2023 and a low of 1.22% during Q3 2022
  • In the last 5 years, Macrogenics' Return on Capital Employed had a median value of 0.53% in 2024 and averaged 0.64%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first soared by 8300bps in 2023, then tumbled by -8300bps in 2024.
  • Quarter analysis of 5 years shows Macrogenics' Return on Capital Employed stood at 0.7% in 2021, then grew by 9bps to 0.64% in 2022, then increased by 0bps to 0.64% in 2023, then grew by 17bps to 0.53% in 2024, then rose by 0bps to 0.53% in 2025.
  • Its Return on Capital Employed stands at 0.53% for Q3 2025, versus 0.4% for Q2 2025 and 0.53% for Q1 2025.